Person Details

James Glover, BS, PMP

James Glover, BS, PMP, Senior Vice President Commercial Manufacturing

Mr. Glover joined Athersys in 2021 as Senior Vice President of Manufacturing. In his role, Mr. Glover is responsible for providing oversight for clinical manufacturing of MultiStem® cell therapy and establishing the long-term strategic plan for commercial manufacturing of the product. Mr. Glover has over 29 years of experience in biologics manufacturing and process development on both a clinical and commercial level.
Prior to joining Athersys, Mr. Glover served as General Manager/Vice President of Drug Substance and Drug Product Manufacturing Operations for Emergent BioSolutions where he led clinical/commercial operations in support of over 45 CMO partnerships. Before joining Emergent, Mr. Glover served as Vice President of Operations for Pharmaceutics International Inc. (Pii) where he managed the entire supply chain for over 20 CMOs in the oral dosage and injectable space. Before his tenure at Pii, Mr. Glover was the Head of Manufacturing and Supply Chain for Dynavax Technologies, Inc. In this position, Mr. Glover was responsible for the clinical to commercial operations management of Dynavax’s first licensed product, Heplisav-B® Hepatitis B vaccine (recombinant), adjuvanted product, manufactured in Dusseldorf, Germany. Prior to that role, Mr. Glover was responsible for the manufacturing operation of Novartis’s (now Grifols) multi-product e-coli and bacterial manufacturing plant. Mr. Glover has also held positions of increasing responsibility at Bayer Pharmaceuticals in the manufacture of Kogenate® FS, Antihemophilic Factor (Recombinant).